Abstract
sCD40L is released from platelets as a soluble, proteolyzed form of CD40 ligand (CD40L; CD154) which is exposed on the surface after platelet activation. Ethylenediaminetetraacetate (EDTA), the CD40-blocking antibody G28-5, and GPIIb-IIIa antagonists are known to inhibit the solubilization when added prior to activation. It is assumed that the surface expression of CD40L is a result of a separate fast process and that the solubilization is secondary to this. The release of sCD40L in this solubilization phase has been studied; that is, inhibitory substances were added to platelet-rich plasma (PRP) 10 min after addition of the activation agonist (100 microM SFLLRN), at which time the secretion phase was over as tested with beta-thromboglobulin (beta-TG). G28-5 (10 microg/ml) and EDTA (5 mM) inhibited the solubilization phase which did not require the presence of an activation agonist. Prostaglandin E1 (PGE1; 20 microM) and cytochalasin D (C8273; 60 and 100 microM), which exert their effects intracellularly, inhibited the solubilization even in the presence of abciximab (ReoPro; 40 microg/ml). The intracellular effect was not related to CD40L-containing microparticles as demonstrated by ultracentrifugation. Intracellular alkaliniz...Continue Reading
References
Dec 1, 1992·European Journal of Immunology·D GrafR A Kroczek
Dec 1, 1992·The Journal of Experimental Medicine·M K SpriggsW C Fanslow
May 7, 1992·Nature·R J ArmitageC R Maliszewski
Apr 1, 1994·Molecular Immunology·L R CoveyS Lederman
Jan 1, 1994·Annual Review of Immunology·J BanchereauS Saeland
Oct 1, 1994·Seminars in Immunology·W C FanslowR J Armitage
Jun 1, 1995·European Journal of Immunology·D GrafR A Kroczek
Sep 23, 1993·Nature·J F GauchatJ Thompson
Mar 1, 1995·European Journal of Immunology·J F GauchatD Aldebert
Apr 1, 1994·Immunological Reviews·R A KroczekL D Notarangelo
Dec 1, 1996·European Journal of Immunology·B LudewigR A Kroczek
Jun 16, 1997·The Journal of Cell Biology·H KashiwagiS J Shattil
Feb 19, 1998·Nature·V HennR A Kroczek
Aug 10, 1999·Circulation·P AukrustL Gullestad
May 11, 2000·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·W ShuretyJ L Stow
Apr 12, 2001·Platelets·A HermannA A Weber
Aug 9, 2001·Blood·V HennR A Kroczek
Sep 13, 2001·Thrombosis Research·K OtterdalN O Solum
Dec 1, 2001·Thrombosis Research·X F WangR C Carroll
Mar 5, 2002·Nature Medicine·Patrick AndréDenisa D Wagner
Jun 19, 2002·Circulation·Lisa Nannizzi-AlaimoHerman K Gold
Feb 4, 2003·Pediatrics·Chih-Lu WangKuender D Yang
Mar 5, 2003·Circulation·Lisa Nannizzi-AlaimoDavid R Phillips
Apr 5, 2003·Circulation Research·David P InwaldNigel J Klein
Jan 26, 2006·Bone Marrow Transplantation·Y TsujiS Mizutani
Citations
Jan 17, 2008·Blood·Daniel L SpragueTimothy L Ratliff
Dec 17, 2009·Infection and Immunity·Ernst Kristian RødlandStig S Frøland
Jul 7, 2009·Archivum Immunologiae Et Therapiae Experimentalis·Jennifer M SowaBennett D Elzey
Apr 8, 2010·Journal of Thrombosis and Thrombolysis·Peter S MunkAlf I Larsen
Mar 13, 2015·Experimental Hematology & Oncology·Antoine DewitteJean Ripoche
Oct 22, 2018·Congenital Heart Disease·Mariana M ClavéAntonio A Lopes
Nov 29, 2007·Internal and Emergency Medicine·F SantilliG Davì
Jun 15, 2007·Critical Reviews in Biochemistry and Molecular Biology·Bénédicte CauweGhislain Opdenakker
Aug 6, 2011·Annals of Medicine·Matteo Nicola Dario Di MinnoElena Tremoli
Dec 20, 2012·PloS One·Donna C DavidsonSanjay B Maggirwar
Aug 26, 2016·Platelets·M MilovanovicP Järemo
Jul 25, 2006·Blood·Kari OtterdalJan K Damås
Oct 4, 2005·Médecine sciences : M/S·Yahsou DelmasJean Ripoche
Oct 27, 2007·American Journal of Respiratory and Critical Care Medicine·Kari OtterdalJan K Damås